FDA Official Gives Policy Update On Lab-Developed Tests

Most laboratory-developed tests have no predicates, said Elizabeth Mansfield, director of personalized medicine in CDRH’s diagnostics office, hinting that many may require pre-market submissions that go beyond 510(k) review standards once the agency initiates plans for active oversight of the category.

More from Archive

More from Medtech Insight